Literature DB >> 6849778

Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.

M B Finch, P C O'Connor, D W Harron, R G Shanks.   

Abstract

1 The present study compared the effects in healthy volunteers of the acute and chronic administration of placebo, pindolol and propranolol to see if the partial agonist activity of pindolol was reduced by the beta-adrenoceptor blocking activity of pindolol on chronic administration. 2 Five subjects received in random order for 8 days placebo, propranolol 160 mg and pindolol 10 mg; on days 1 and 8 treatments were given twice at 0 and 2 h. Heart rate in supine position and at end of exercise was recorded before dosing and at 2 and 4 h post-dosing on days 1 and 8. 3 Propranolol and pindolol reduced exercise heart rate to the same extent on days 1 and 8. 4 Propranolol reduced supine heart rate more than pindolol on days 1 and 8 but the difference was only significant on day 8.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849778      PMCID: PMC1427788          DOI: 10.1111/j.1365-2125.1983.tb01526.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.

Authors:  R Gugler; W Höbel; G Bodem; H J Dengler
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

2.  Letter: Paradoxical effect of pindolol.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Br Med J       Date:  1975-07-19

3.  The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.

Authors:  P Imhof
Journal:  Adv Clin Pharmacol       Date:  1976

Review 4.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Acute hemodynamic effects of five beta-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity.

Authors:  T Lysbo Svendsen; J Trap-Jensen; J Bliddal; O Hartling; A McNair
Journal:  Acta Med Scand Suppl       Date:  1979

Review 6.  The properties of beta-adrenoceptor antagonists.

Authors:  R G Shanks
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

7.  Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

8.  Comparative chronotropic activity of beta-adrenoceptive antagonists.

Authors:  A M Barrett; J Carter
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

9.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Measurement of partial agonist activity of pindolol.

Authors:  S G Carruthers; Y Twum-Barima
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

View more
  4 in total

1.  Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.

Authors:  P C O'Connor; J M Arnold; A N Brown; R J Francis; M B Finch; D B Galloway; D W Harron; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

Review 2.  "Sit back, observe, and wait." Or is there a pharmacologic preventive treatment for cerebral aneurysms?

Authors:  Marcelo M Valença
Journal:  Neurosurg Rev       Date:  2012-10-16       Impact factor: 3.042

3.  Effect on heart rate over 24 hours of pindolol administered for 14 days.

Authors:  J P Kantelip; J F Trolese; P G Cromarias; P Duchêne-Marullaz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.

Authors:  T H Pringle; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.